Three decades of CKD due to diabetes mellitus type 2 in China, with projections of disease burden from 2022 to 2036: a systematic analysis for the Global Burden of Disease Study 2021

中国2型糖尿病慢性肾脏病三十年发展情况及2022年至2036年疾病负担预测:2021年全球疾病负担研究的系统分析

阅读:1

Abstract

BACKGROUND: A comprehensive assessment of disease burden is critical for optimizing management strategies for chronic kidney disease (CKD) due to type 2 diabetes (T2DM) in China. This study analyzes 30-year trends (1990-2021) in T2DM-related CKD burden, epidemiological characteristics, 15-year projections and dietary risk factors in China. METHODS: Data from the Global Burden of Disease Study (GBD) were used to examine prevalence, incidence, deaths, disability-adjusted life years (DALYs), years lived with disability (YLDs) and years of life lost (YLLs) stratified by age, sex and year. Analytical methods included joinpoint regression to identify trend changes, age-period-cohort modeling to disentangle demographic effects, decomposition analysis to assess drivers (aging, population growth, epidemiological shifts), autoregressive integrated moving average (ARIMA) forecasting for 2022-36 projections and dietary risk factor analysis focusing on seven modifiable dietary factors. RESULTS: From 1990 to 2021, T2DM-related CKD burden showed a consistent upward trend. In 2021, prevalence reached 20.91 million cases [age-standardized rate (ASR) 1053.92/100 000], a 75.87% increase from 1990. Incidence and mortality rose by 177.64% and 147.26%, respectively, with 354 000 new cases and 108 000 deaths. Males exhibited higher ASRs than females across all outcomes, and the 70-94 years age group bore the highest burden. Aging was the primary driver of burden growth. Projections (2022-36) indicate declining age-standardized prevalence but rising trends in incidence, mortality, DALYs and YLLs, with stable YLDs. Key dietary risks included high red-meat consumption and low intake of whole grains and fruits. CONCLUSIONS: While age-standardized rates for some outcomes may decline, absolute burdens of T2DM-related CKD in China are increasing, driven by population aging. Strengthening healthcare systems, enhancing risk factor screening (e.g. dietary interventions) and improving diabetes management are imperative for prevention and control.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。